Do Patient-Centric mHealth Programs Improve Patient Engagement and Health Outcomes.
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 5/4/2016 |
| Start Date: | April 2016 |
| End Date: | March 2017 |
| Contact: | Ruchi Mathur, MD |
| Email: | Ruchi.mathur@cshs.org |
| Phone: | (310) 423-4295 |
The "INTELLIH" (brand name of the mobile health application) Diabetes Study is to understand
the usage of a mobile health application, IntelliH, and connected wireless devices such as
glucometer by the diabetic patients and ascertain if there are any improvements in
short-term health outcomes.
the usage of a mobile health application, IntelliH, and connected wireless devices such as
glucometer by the diabetic patients and ascertain if there are any improvements in
short-term health outcomes.
The proposed pilot program is the first of its kind in the nation to use a product,
"IntelliH" - Intelligent Health for All, that combines four key technologies in one
platform: 1) Mobile health application (mHealth) App and web portal, 2) wireless sensors and
wearable devices, 3) Secure text messaging when both sender and receiver are logged in to
the system and video-based patient interaction, and 4) remote health monitoring. The purpose
of this pilot program is to understand a) usage and adoption of these technologies by
providers and patients, and b) document the short-term improvements in health outcomes in a
diabetic population. This pilot study will follow 20 diabetic patients (Type 1 or Type 2) as
they beta-test this system, and will acquire data on consented subjects over a period of six
months.
"IntelliH" - Intelligent Health for All, that combines four key technologies in one
platform: 1) Mobile health application (mHealth) App and web portal, 2) wireless sensors and
wearable devices, 3) Secure text messaging when both sender and receiver are logged in to
the system and video-based patient interaction, and 4) remote health monitoring. The purpose
of this pilot program is to understand a) usage and adoption of these technologies by
providers and patients, and b) document the short-term improvements in health outcomes in a
diabetic population. This pilot study will follow 20 diabetic patients (Type 1 or Type 2) as
they beta-test this system, and will acquire data on consented subjects over a period of six
months.
Inclusion Criteria:
A1c greater than or equal to 6.5%. Age greater than or equal to 18 years. Ability to
comply with study protocol. Available and usable internet facilities at home. Availability
and usable smart phone.
Exclusion Criteria:
Inability to comply with instructions and directions.
We found this trial at
1
site
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
Click here to add this to my saved trials
